Vision-dependent behavior is a form of behavior that relies on visual information. It is most common among animals but can also be found in humans. Animals usually rely on their vision, either in the form of clearly perceiving their surroundings or responding to visual stimuli, to aid them in their day-to-day living. In humans, vision-dependent behavior can manifest in a variety of ways. An example of this is learning a new skill. Many humans rely on visual clues to help them understand the concept they are trying to learn. This visual information can be in the form of diagrams, video or even text that helps a person to interpret what they are seeing and make sense of it. Vision is also important in helping humans evaluate their environment. The ability to see details about the physical environment is what allows humans to make informed decisions and respond appropriately. For example, when a person sees a potentially dangerous situation they can take measures to protect themselves such as looking away or moving away from the area. In terms of animal behavior, vision-dependent behavior can be observed when animals are foraging for food. By being able to visually analyze their environment they can decide on the best object to consume and also recognize potential predators. Animals also use vision-dependent behavior when they interact with members of the same species. For example, they can use visual cues to figure out the dominance hierarchy within their group.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States